Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Experimental Hematology|June 9, 2004
Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantationGregory Elkin, Tatyana B Prigozhina, Shimon Slavin
Experimental Hematology|November 13, 2004
Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioningTatyana B Prigozhina, Gregory Elkin, Sofia Khitrin, et al.
Experimental Hematology|September 24, 2008
Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantationTatyana B Prigozhina, Gregory Elkin, Sofia Khitrin, et al.
Experimental Hematology|February 2, 2002
Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical modelsTatyana B Prigozhina, Olga Gurevitch, Shoshana Morecki, et al.
Experimental Hematology|July 16, 2008
Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantationTatyana B Prigozhina, Sofia Khitrin, Gregory Elkin, et al.
Experimental Hematology|January 25, 2003
CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cellsTatyana B Prigozhina, Olga Gurevitch, Gregory Elkin, et al.
American Journal of Blood Research|March 21, 2012
Visualization of immune response kinetics in full allogeneic chimerasGregory Elkin, Tatyana B Prigozhina, Shimon Slavin, et al.
Virology Journal|February 19, 2009
Analysis of adenoviral attachment to human plateletsNilly Shimony, Gregory Elkin, Dror Kolodkin-Gal, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipientsTatyana B Prigozhina, Gregory Elkin, Olga Gurevitch, et al.
Cancer Letters|August 30, 2008
A novel dynamic matrix detachment model reveals a shift from apoptosis to necrosis in melanoma cellsKeren Tzukert, Raphael Gorodestky, Idit Avrahami, et al.
Pageof 2